Results for “”

Entry Author Date Location
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer 02/12/20 San Francisco
Ligand’s Icagen Deal Brings Neuro, CF Assets Plus Partnering Potential 02/12/20 San Diego
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019 02/12/20 National
Two Big Pharma Alliances End in Nixed Deals. Here’s What Happened. 02/11/20 National
FDA Clinical Hold Stops LogicBio’s Gene Editing Study Before It Starts 02/10/20 Boston
Wave Life Sciences’ Stumble in Duchenne Leads to 22% Staff Layoff 02/10/20 Boston
Biohaven Drug Fails Anxiety Study, Data in OCD and More Still to Come 02/10/20 New York
Eli Lilly, Roche Drugs Fail to Move Needle in Genetically Driven Alzheimer’s 02/10/20 National
Complexa Appoints Elisabeth Leiderman Chief Business Officer 02/07/20 National
Bio Roundup: POTUS on Prices, a16z’s Fund, Aimmune’s Approval & More 02/07/20 National
Myriad Genetics Exec Capone Resigns, Riggsbee Named Interim CEO 02/06/20 National
Sonoma Bio Launches With $40M to Take Cell Therapy Beyond Cancer 02/06/20 San Francisco
Scripps Research’s Calibr to Test “Switchable” CAR-T in Clinical Trial 02/06/20 San Diego
Early Bird Sale Ending for San Diego’s Xcelerating Life Sciences Conference 02/06/20 National
Beam Therapeutics IPO Raises $180M After Nearly Doubling Shares Offered 02/06/20 Boston
Coda Bio Acquires Drug Candidates to Pair With Engineered Receptors 02/06/20 San Francisco
Aimmune Gets $200M From Nestlé; Licenses Food Allergy Drug Candidate 02/05/20 San Francisco
Merck Charts an R&D-Focused Course Starting With a $6.5B Spinoff 02/05/20 New York
Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA 02/04/20 National
Verily, Santen See Ophthalmology Opportunity Via New Joint Venture 02/04/20 San Francisco
$750M Fund Looks to Software Sector to Drive Future of Biotech 02/04/20 National
Bristol-Myers, BioMotiv Pact Leads to a New Fibrosis-Focused Startup 02/04/20 New York
Passage Bio Plans IPO as Three Gene Therapies Approach the Clinic 02/03/20 New York
Insmed Drug for Rare Pulmonary Disorder Meets Phase 2 Goals 02/03/20 New York
United Therapeutics Drug Flunks Small Cell Lung Cancer Clinical Trial 02/03/20 National
Discovery Labs Converts ex-GSK King of Prussia Site into R&D “Colony” 02/03/20 New York
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy 01/31/20 San Francisco
Arcutis Bio Raises $159M in Upsized IPO to Test Skin Disease Drugs 01/31/20 San Diego
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More 01/31/20 National
BIO Report: More Work Needed to Improve Diversity at Biotech Firms 01/30/20 National
Page 2 of 871 « previous page · next page »